PTR-01
PTR-01-003
Phase 2 small_molecule completed
Quick answer
PTR-01 for Recessive Dystrophic Epidermolysis Bullosa is a Phase 2 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BridgeBio Oncology Therapeutics
- Indication
- Recessive Dystrophic Epidermolysis Bullosa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed